BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2026 9:40:38 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-04-02 02:09 |
|
Peer-Review Started |
|
2026-04-02 02:10 |
|
First Decision by Editorial Office Director |
|
2026-05-13 01:27 |
|
Return for Revision |
|
2026-05-13 01:43 |
|
Revised |
|
2026-05-13 03:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-05-25 02:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-25 06:32 |
|
Articles in Press |
|
2026-05-25 06:32 |
|
Edit the Manuscript by Language Editor |
|
2026-06-04 09:03 |
|
Typeset the Manuscript |
|
2026-06-25 08:08 |
|
Publish the Manuscript Online |
|
2026-07-13 09:40 |
| ISSN |
1948-5204 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
New-onset diabetes and pancreatic cancer: Current evidence on absolute risk and screening feasibility
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Seoung Hoon Kim |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Seoung Hoon Kim, MD, Senior Scientist, Organ Transplantation Center, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, South Korea. kshlj@hanmail.net |
| Key Words |
Pancreatic cancer; New-onset diabetes; Risk stratification; Absolute risk; Early detection |
| Core Tip |
New-onset diabetes (NOD) is a reproducible clinical signal associated with pancreatic ductal adenocarcinoma, but its absolute cancer risk remains low. This minireview summarizes recent prospective cohort data, risk stratification models, and screening-related evidence showing why NODs should not be used as a screening indication. Instead, it should be considered a gatekeeper for stepwise risk enrichment, with future efforts focused on clinically actionable absolute-risk thresholds, biomarkers, and prospective validation. |
| Publish Date |
2026-07-13 09:40 |
| Citation |
Kim SH. New-onset diabetes and pancreatic cancer: Current evidence on absolute risk and screening feasibility. World J Gastrointest Oncol 2026; 18(7): 121817
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i7/121817.htm |
| DOI |
https://doi.org/10.4251/wjgo.v18.i7.121817 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
